BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 1997
View Archived Issues
New NMDA antagonists from Merck KGaA
Read More
Angiogenesis inhibitors described by Janssen
Read More
Novo Nordisk presents potassium channel openers/blockers
Read More
Novartis prepares protein tyrosine kinase inhibitors
Read More
Short-term efficacy and safety of T-20 in HIV infection
Read More
Oxandrolone + glutamine for HIV-associated wasting
Read More
AIDS dementia reversed by highly active antiretroviral therapy
Read More
Spotlight on bisphosphonates in osteoporosis
Read More
LY-303366: efficacy in rabbits with invasive pulmonary aspergillosis
Read More
Nonsteroidal inhibitors of steroid C17,20-lyase developed at Yamanouchi
Read More
Yamanouchi develops potent and selective PDE IV inhibitors
Read More
Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist
Read More
Osteoporosis indication for tiludronate dropped
Read More
Colonic prokinetic agent discovered by Janssen
Read More
Irbesartan introduced in first markets
Read More
Crinone approved for marketing in Germany
Read More
Labeling changes for Seldane products
Read More
Twinrix approved for marketing in Canada
Read More
FDA grants final marketing approval for Corlopam
Read More
L-Arginine for liver ischemia/reperfusion injury and transplantation
Read More
FTY-720: novel immunosuppressant for combination therapy
Read More
Draxis Health subsidiary initiates phase I testing of DVT diagnostic agent
Read More
rNAPc2 completes phase Ia testing with positive results
Read More
Phase III trial of Neuprex in meningococcemia continues; pilot trial in CF begins
Read More
Positive efficacy results obtained in phase II trial of ALX1-11; phase III trials will begin soon
Read More
Alliance and Schering AG sign agreement for Imagent US
Read More